A direct comparison of the masculinizing effects of testosterone, androstenedione, estrogen, and progesterone on the development of the zebra finch song system.
To assess which hormones are capable of masculinizing the neural song system of zebra finch hatchlings, we implanted female hatchlings with estrogen (estradiol [E2], 75 micrograms, n = 9), testosterone (T, 75-88 micrograms, n = 13), androstenedione (AE, 75 micrograms, n = 7), progesterone (P, 117 micrograms, n = 10), or nothing (Blanks, n = 10) and compared these to unimplanted males (n = 7). Implants, consisting of a hormone and Silastic mixture encased in polyethylene tubing, were placed under the skin of the breast on the day of hatching. Birds were killed when they were sub-adult (58 to 68 days old). We measured volumes of area X, the higher vocal center (HVC), and the robust nucleus of the archistriatum (RA); measured soma sizes in the lateral magnocellular nucleus of the neostriatum (lMAN), HVC, and RA; and counted RA neurons. E2 masculinized all measures in the song system and nearly sex-reversed the size of RA neurons. T masculinized volumes of nuclei and soma sizes but not the number or spacing of RA neurons. E2 was always at least as effective as T in masculinizing measures of the song system and was usually more effective. AE and P did not significantly masculinize any measure. These data suggest that E2 is more potent than aromatizable androgens or P in masculinizing the female song system in development and that the action of E2 alone may be sufficient to masculinize the volume of song control nuclei and the size and number of neurons.
Grisham
W
W
Department of Psychology, University of California, Los Angeles 90024-1563, USA.
Arnold
A P
AP
D000735:Androstenedione / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn / Q000502:physiology*; D001717:Birds / Q000502:physiology*; D004967:Estrogens / Q000494:pharmacology*; D005260:Female; D008297:Male; D017072:Neostriatum / Q000187:drug effects / Q000502:physiology; D009474:Neurons / Q000502:physiology; D011374:Progesterone / Q000494:pharmacology*; D012727:Sex Characteristics; D013739:Testosterone / Q000494:pharmacology*; D014828:Vocalization, Animal / Q000187:drug effects*
D004967:Estrogens; D013739:Testosterone; D000735:Androstenedione; D011374:Progesterone